pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Bosulif
drug
save

Bosulif

Marketedupdated 3mo ago
by $PFE PFIZER INC
Approved
community read0 votes

🐶 often sniffed alongside

top 4
  • tagApproval94 co-mentions · 24 sources
  • drugBOSUTINIB MONOHYDRATE47 co-mentions · 24 sources
  • tagSmall Molecule47 co-mentions · 24 sources
  • drugbosutinib47 co-mentions · 24 sources

all catalysts(0)

nothing on the calendar yet

Trials studying Bosulif

  • phase3Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIscompletedn=233
  • phase2iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Studycompletedn=46
  • phase4Asciminib Roll-over Studyrecruitingn=347
  • —A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).recruitingn=600
  • phase3A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPactive not recruitingn=405
  • phase2Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)recruitingn=720
  • phase2Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemiaactive not recruitingn=60
  • phase3Study of Olverembatinib (HQP1351) in Patients With CP-CMLrecruitingn=285
more trials →

News(0)

no news has mentioned this drug yet

brand
Bosulif
generic
bosutinib
indication
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 15m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?